ArticleSmart molecules : open access2026
Photo-induced proton release of spiropyran-derived nanomaterials for mRNA delivery in hard-to-transfect cells.
Article in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Messenger RNA (mRNA) therapy has been explored as a treatment for various genetic disorders. Significant progress has been made in developing mRNA delivery systems. However, efficient delivery of mRNA in hard-to-transfect cells remains a considerable challenge. Here, we constructed a series of spiropyran-derived lipid-like materials, named SPALs, to enhance mRNA delivery efficiency in cells that are difficult to transfect. In this design, we focused on strengthening the internal escape mechanism of mRNA nanoparticles via photo-induced proton production by SPALs. Specifically, the spiropyran structure can undergo ring-closing isomerization under light irradiation (460 nm) and produce a proton. The protons then mediate the protonation of tertiary amines in the lipid tail in situ, which subsequently disrupts the potential and size of nanoparticles and finally promotes their endosome escape. It ultimately enhances mRNA expression in live cells. SPALs are demonstrated to reduce the pH value up to 0.53 pH units after light irradiation in solution. They are also proven to decrease the pH value after light irradiation as observed through fluorescence ratio imaging in live cells. After screening the materials, we identified SPAL1 as a lead material for increasing the enhanced green fluorescent protein-positive rate in Raw 264.7 cells by 22% after light irradiation, from 59% to 72%. This transfection efficiency is significantly higher than that of the lipo3000 in the same cell line. Consequently, we developed a new strategy to improve mRNA transfection efficiency, which merits further evaluation and development for mRNA-based therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.